DKC1 Overexpression Induces a More Aggressive Cellular Behavior and Increases Intrinsic Ribosomal Activity in
Ania Naila Guerrieri1,2, Federico Zacchini1,2, Carmine Onofrillo1,2
1Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy.
Cancers
|December 1, 2020
Summary
High levels of dyskerin protein in breast cancer correlate with poorer survival and aggressive tumors. Dyskerin overexpression enhances ribosome function and promotes a more aggressive cellular phenotype, potentially driving early-stage cancer progression.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Dyskerin (DKC1) is a nucleolar protein crucial for RNA modification and telomerase maintenance.
- Mutations in DKC1 cause X-linked dyskeratosis congenita, while its overexpression is observed in various tumors.
- High dyskerin levels in primary breast cancers are linked to shorter survival and positive lymph node status.
Purpose of the Study:
- To investigate the functional consequences of dyskerin overexpression in breast cancer.
- To determine the impact of elevated dyskerin on cellular phenotype and ribosome function.
- To explore the role of dyskerin in early-stage breast cancer development.
Main Methods:
- Generation of stable DKC1-overexpressing cell models (MCF10A).
- Analysis of small nucleolar RNA (snoRNA) levels and ribosomal RNA (rRNA) modifications.
- Assessment of ribosome synthetic activity and translational efficiency.
Main Results:
- DKC1 overexpression induced a more aggressive cellular phenotype in MCF10A cells.
- Elevated dyskerin upregulated specific snoRNAs (e.g., SNORA67) and increased 18S rRNA U1445 modification.
- Dyskerin overexpression significantly enhanced ribosome synthetic activity and translational efficiency.
Conclusions:
- Dyskerin may promote an early neoplastic phenotype in breast cancer by enhancing translational efficiency.
- Increased dyskerin levels contribute to a more aggressive cellular phenotype and potentially poorer patient outcomes.
- Dyskerin's role in ribosome function offers a potential therapeutic target in breast cancer treatment.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
4.2K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.2K
02:23Abnormal Proliferation
4.9K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
02:38Mitogens and the Cell Cycle
7.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.4K
01:06Induced Pluripotent Stem Cells
4.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.9K
02:34Inhibition of Cdk Activity
5.4K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
02:38The Ras Gene
6.8K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.8K